A pilot study of treatment of social phobia with alprazolam



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Reich, J.
	Articles by Yates, W.
	Search for Related Content



	PubMed Citation
	Articles by Reich, J.
	Articles by Yates, W.

Am J Psychiatry 1988; 145:590-594
Copyright © 1988 by American Psychiatric Association

REGULAR ARTICLES

A pilot study of treatment of social phobia with alprazolam

J Reich and W Yates
Department of Psychiatry, University of Iowa College of Medicine, Iowa City.

Fourteen patients with DSM-III social phobia were treated with alprazolam in an open study. Multiple measures of symptoms and disability showed significant improvement. The symptoms improved during the first and second weeks, and disability improved at 3 weeks and beyond. After medication withdrawal the symptom and disability measures were no longer significantly different from those at baseline.

This article has been cited by other articles:

R. G. Heimberg, M. R. Liebowitz, D. A. Hope, F. R. Schneier, C. S. Holt, L. A. Welkowitz, H. R. Juster, R. Campeas, M. A. Bruch, M. Cloitre, et al.
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Arch Gen Psychiatry, December 1, 1998; 55(12): 1133 - 1141.
[Abstract] [Full Text] [PDF]

B. C. Donohue, V. B. Van Hasselt, and M. Hersen
Behavioral Assessment and Treatment of Social Phobia: An Evaluative Review
Behav Modif, July 1, 1994; 18(3): 262 - 288.
[Abstract]

Get information about faster international access.